Related Experiment Videos
Immunopathological recognition of autoantigens in multiple sclerosis
1Neuroimmunology Laboratory, La Trobe University, Bundoora, Australia.
Acta Neurologica
|April 1, 1991
Summary
Multiple sclerosis (MS) involves immune responses, but T cell reactivity to myelin basic protein (MBP) showed no significant difference. T cell receptor (TcR) gene variations and limited TcR usage in lesions suggest specific antigen recognition in MS.
Area of Science:
- Neuroimmunology
- Autoimmune Diseases
Background:
- Multiple sclerosis (MS) etiology is unknown, but immune responses are implicated in demyelination.
- Controversy exists regarding T lymphocyte reactivity to myelin basic protein (MBP) in MS patients.
Purpose of the Study:
- To reassess T cell reactivity to MBP in MS patients using a sensitive indicator of cell-mediated immunity.
- To investigate the role of T cell receptor (TcR) polymorphism and usage in MS pathogenesis.
- To explore myelin components, like myelin-oligodendrocyte glycoprotein (MOG), as potential targets in MS.
Main Methods:
- Assessed T cell reactivity to MBP in MS patients and controls.
- Analyzed T cell receptor (TcR) alpha chain polymorphism in relation to MS.
- Examined TcR usage in demyelinating lesions.
- Investigated the demyelinating effects of anti-myelin-oligodendrocyte glycoprotein (MOG) antibodies in vitro.
Main Results:
- No significant difference in MBP reactivity between MS patients and healthy subjects.
- Significant MBP reactivity was found in control patients with other diseases.
- TcR alpha chain polymorphism is associated with MS, and TcR usage in lesions is restricted.
- Anti-MOG antibodies demonstrated demyelinating effects in vitro.
Conclusions:
- T cells may recognize specific epitopes of a critical antigen in MS, potentially MOG.
- While MBP reactivity is not a distinguishing factor, TcR genetics and MOG's role warrant further investigation in MS pathogenesis.